156 related articles for article (PubMed ID: 24375315)
1. Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.
Eissa S; Matboli M; Mansour A; Mohamed S; Awad N; Kotb YM
Med Oncol; 2014 Feb; 31(2):804. PubMed ID: 24375315
[TBL] [Abstract][Full Text] [Related]
2. Potential molecular marker for detecting transitional cell carcinoma.
Chiu AW; Huang YL; Huan SK; Wang YC; Ju JP; Chen MF; Chou CK
Urology; 2002 Jul; 60(1):181-5. PubMed ID: 12100959
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma.
Huang YL; Chiu AW; Huan SK; Wang YC; Ju JP; Lu CL
Anticancer Res; 2003; 23(3B):2729-33. PubMed ID: 12894566
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer.
Shabayek MI; Sayed OM; Attaia HA; Awida HA; Abozeed H
Pathol Oncol Res; 2014 Oct; 20(4):859-66. PubMed ID: 24696417
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.
Eissa S; Zohny SF; Zekri AR; El-Zayat TM; Maher AM
Med Oncol; 2010 Dec; 27(4):1286-94. PubMed ID: 20012564
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of bilharzial bladder. Diagnostic value of urine cytology.
el-Bolkainy MN; Ghoneim MA; el-Morsey BA; Nasr SM
Urology; 1974 Mar; 3(3):319-23. PubMed ID: 4819693
[No Abstract] [Full Text] [Related]
8. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM
J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
[TBL] [Abstract][Full Text] [Related]
12. Urinary retinoic acid receptor-β2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer.
Eissa S; Zohny SF; Shehata HH; Hegazy MG; Salem AM; Esmat M
Clin Biochem; 2012 Apr; 45(6):402-7. PubMed ID: 22286019
[TBL] [Abstract][Full Text] [Related]
13. The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors.
Smrkolj T; Cegovnik Primozic U; Fabjan T; Sterpin S; Osredkar J
Radiol Oncol; 2020 Dec; 55(2):196-202. PubMed ID: 33764701
[TBL] [Abstract][Full Text] [Related]
14. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
16. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
[TBL] [Abstract][Full Text] [Related]
17. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
[TBL] [Abstract][Full Text] [Related]
18. Urine carcinoembryonic antigen determination in urinary bladder bilharziasis predicts carcinoma in patients with premalignant lesions: observation of 43 cases in Egypt.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
Tanzan Health Res Bull; 2006 Sep; 8(3):122-7. PubMed ID: 18254501
[TBL] [Abstract][Full Text] [Related]
19. Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis.
Eissa S; Shawky SM; Matboli M; Mohamed S; Azzazy HM
Clin Biochem; 2014 Jan; 47(1-2):104-10. PubMed ID: 24183881
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]